Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07526051

Effects of Autogenic Inhibition Versus Reciprocal Inhibition in Individuals With Lower Cross Syndrome

This study examines the effects of autogenic inhibition (PFS) versus reciprocal inhibition in individuals with lower cross syndrome

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Lower Cross Syndrome

Age range

25 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Participants were randomly assigned into two groups Group A received Autogenic Inhibition (PFS) technique focusing on lengthening of chronically shortened muscles Group B received Reciprocal Inhibition technique focusing on lengthening of chronically shortened muscles Pain, Functional Disability , Muscular strength, Lumbar and Hip Rom were measured using VAS, ODI, Sphygmomanometer, Inclinometer and Goniometer

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Both Males and Females will be included in our study Age 25-50 years Four positive screening tests (Thomas Test, Abdominal Strength Test, Glutues Maximus Test, Ely's Test) chronic Pain in lower Back Region (>3 on VAS) lasting for more than 2 months

Exclusion criteria

  • Osteoporosis Congenital Hip Dysplasia History of Fracture History of Inflammatory Arthritis Pregnancy

Treatment and study plan

Autogenic Inhibition (PFS) Group A

Procedure

Patient will receive a four-week physiotherapy program with 3 sessions per week. Each session with heat application followed by supervised stretching and strengthening exercises.

Participants in group A will receive Autogenic Inhibition (PFS) 10 minutes TENS & Heating Pad Autogenic Inhibition for 5 sec 5 reps, 5 sec hold,1 set Frequency: 12 sessions for 4 weeks (3 sessions per week and day of rest between sessions) Total Treatment Time 30 minutes each session Strengthening Exercises for Hip and Core Muscles

Reciprocal Inhibition Group B

Procedure

Patient will receive a four-week physiotherapy program with 3 sessions per week. Each session with heat application followed by supervised stretching and strengthening exercises. Participants in group B will receive Reciprocal Inhibition 10 minutes TENS & Heating Pad Inhibition for 5 sec 5 reps,5 sec hold,1 set Frequency: 12 sessions for 4 weeks (3 sessions per week and day of rest between sessions) Total Treatment Time 30 minutes each session Strengthening Exercises for Hip and Core Muscles

Primary outcomes

  1. Lumbar Range of Motion

    Time frame: Baseline, 2nd week and 4th week

    Lumbar spine range of motion will be assessed using inclinometer

  2. Hip Range of Motion

    Time frame: Baseline, 2nd week and 4th week

    Hip range of motion will be assessed using Goniometer

  3. Functional Disability

    Time frame: Baseline, 2nd week and 4th week

    Functional Disability will be measured with Oswestry disability Index, a ten item questionnaire with 6 response options per item.

Secondary outcomes

  1. Pain Intensity

    Time frame: Baseline, 2nd week and 4th week

    Pain intensity will be measured with VAS ranging from 0 (no pain) to 10 (worst pain)

  2. Muscles Strength (Gluteus & Core Muscles)

    Time frame: Baseline, 2nd week and 4th week

    Muscles strength will be assessed using sphygmomanometer

Study contacts

Contact information is provided by the study sponsor or research team.

Ruqia Begum, MS-OMPT

CONTACT

[email protected]

03115532544

Zobia Noor, DPT

CONTACT

[email protected]

0334-8962818

Sponsors and collaborators

Lead sponsor

Foundation University Islamabad

Other

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Apr 13, 2026
Registry last updated
May 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.